146 related articles for article (PubMed ID: 26915336)
1. p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.
Manso R; Roncador G; Montes-Moreno S; Rojo F; Pérez-Sáenz MÁ; Mollejo M; Menárguez J; Carvajal N; García-Cosio M; Llamas P; Piris MA; Rodríguez-Pinilla SM
Br J Haematol; 2017 Feb; 176(4):661-664. PubMed ID: 26915336
[No Abstract] [Full Text] [Related]
2. BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.
Ratajczak P; Leboeuf C; Wang L; Brière J; Loisel-Ferreira I; Thiéblemont C; Zhao WL; Janin A
Mod Pathol; 2012 Jun; 25(6):805-14. PubMed ID: 22322190
[TBL] [Abstract][Full Text] [Related]
3. CD20 expression in angioimmunoblastic T cell lymphoma.
Foukas PG; Kefala M; Papageorgiou S; Tsirigotis P; Panayiotidis P; Korkolopoulou P; Spathis A; Dervenoulas J; Patsouris E; Karakitsos P; Panayiotides IG
Leuk Lymphoma; 2012 Feb; 53(2):345-7. PubMed ID: 21919822
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma.
Kawano R; Ohshima K; Wakamatsu S; Suzumiya J; Kikuchi M; Tamura K
Haematologica; 2005 Sep; 90(9):1192-6. PubMed ID: 16154842
[TBL] [Abstract][Full Text] [Related]
5. Bone Marrow Infiltration of Angioimmunoblastic T-Cell Lymphoma: Identification and Prognostic Impact of Histologic Patterns and Diagnostic Application of Ancillary Phenotypic and Molecular Analyses.
Gerlach MM; Juskevicius D; Vela V; Dirnhofer S; Tzankov A
Arch Pathol Lab Med; 2020 May; 144(5):602-611. PubMed ID: 31556696
[TBL] [Abstract][Full Text] [Related]
6. Expression of multiple cytokines and chemokine receptor 4 in angioimmunoblastic T-cell lymphoma with abundant plasma cell infiltration involving the skin.
Nakayama S; Yokote T; Hiraoka N; Nishiwaki U; Hanafusa T; Tsuji M
Br J Haematol; 2017 May; 177(4):656-659. PubMed ID: 27072191
[No Abstract] [Full Text] [Related]
7. [Angioimmunoblastic T cell lymphoma with Reed-Sternberg-like cells].
Liu YH; Zhuang HG; Luo DL; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):249-50. PubMed ID: 16776988
[No Abstract] [Full Text] [Related]
8. c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis.
Bisig B; Thielen C; Herens C; Gofflot S; Travert M; Delfau-Larue MH; Boniver J; Gaulard P; de Leval L
Histopathology; 2012 Jan; 60(2):371-6. PubMed ID: 22126447
[No Abstract] [Full Text] [Related]
9. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.
Iqbal J; Weisenburger DD; Greiner TC; Vose JM; McKeithan T; Kucuk C; Geng H; Deffenbacher K; Smith L; Dybkaer K; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Au WY; Ko YH; Sng I; Armitage JO; Chan WC;
Blood; 2010 Feb; 115(5):1026-36. PubMed ID: 19965671
[TBL] [Abstract][Full Text] [Related]
10. ITK/SYK translocation in angioimmunoblastic T-cell lymphoma.
Attygalle AD; Feldman AL; Dogan A
Am J Surg Pathol; 2013 Sep; 37(9):1456-7. PubMed ID: 24076779
[No Abstract] [Full Text] [Related]
11. Infectious mononucleosis-like lesions, a rare manifestation of angioimmunoblastic T-cell lymphoma.
Xie JL; Zhou XG
Leuk Lymphoma; 2010 May; 51(5):944-6. PubMed ID: 20350275
[No Abstract] [Full Text] [Related]
12. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Schlegelberger B; Zwingers T; Hohenadel K; Henne-Bruns D; Schmitz N; Haferlach T; Tirier C; Bartels H; Sonnen R; Kuse R
J Clin Oncol; 1996 Feb; 14(2):593-9. PubMed ID: 8636776
[TBL] [Abstract][Full Text] [Related]
13. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
[TBL] [Abstract][Full Text] [Related]
14. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
[TBL] [Abstract][Full Text] [Related]
15. c-Maf expression in angioimmunoblastic T-cell lymphoma.
Murakami YI; Yatabe Y; Sakaguchi T; Sasaki E; Yamashita Y; Morito N; Yoh K; Fujioka Y; Matsuno F; Hata H; Mitsuya H; Imagawa S; Suzuki A; Esumi H; Sakai M; Takahashi S; Mori N
Am J Surg Pathol; 2007 Nov; 31(11):1695-702. PubMed ID: 18059226
[TBL] [Abstract][Full Text] [Related]
16. Primary cerebral angioimmunoblastic T-cell lymphoma.
Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
[No Abstract] [Full Text] [Related]
17. IDH2
Riva M; Tisi MC; Bertorelle R; Famengo B; D'Amore ESG; Pizzi M; Parisi A; Boscato E; Mazzucco M; Semenzato G; Krampera M; Gherlinzoni F; Trentin L; Ruggeri M; Visco C; Stefani PM; Piazza F
Eur J Haematol; 2023 Feb; 110(2):217-220. PubMed ID: 36264618
[No Abstract] [Full Text] [Related]
18. No correlation between immunoglobulin heavy chain rearrangements and the prognosis of angioimmunoblastic T-cell lymphoma.
Niino D; Kawano R; Arakawa F; Sugita Y; Suefuji N; Ohshima K
Eur J Haematol; 2009 Aug; 83(2):159-60. PubMed ID: 19467019
[No Abstract] [Full Text] [Related]
19. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma development].
Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2016 Aug; 57(8):1038-43. PubMed ID: 27599421
[TBL] [Abstract][Full Text] [Related]
20. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]